TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in Oxytocin Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Oxygen saturation value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Time to recover
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Motor Skill Acquisition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in acute anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain During Activities at 1-Year Post-Surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hand Function at 1-Year Post-Surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Handwriting Skills
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Safety of TDS
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum tolerated dose (MTD) or maximum administered dose (MAD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Digital Health Literacy Instrument 2.0 scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of right answers on digital health visualization questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early graft dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Colic symptoms reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cumulative equivalent morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular Adverse Events in treated eyes/safety
Endpoint domain: Adverse events/effects
Primary endpoint: Lack of occurrence of a Severe Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Nutritional score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Slow vital capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Maximal voluntary ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Maximum phonation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Serum levels of CD147
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Multiparametric MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of ultrasound elastography guided pleural biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: User satisfaction as assessed by The Participant Satisfaction Survey
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants With Clinically Significant Changes in Electrocardiogram (ECG) Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Conjunctival Epithelium Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conjunctival Stroma Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tenon's Capsule Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sum of Conjunctival Epithelium, Stroma and Tenon's Capsule Thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants in Age Groups
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Infection-related readmission rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rates of interictal epileptiform discharges on EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: One-Year Overall Survival Rate
Endpoint domain: Mortality/survival
Primary endpoint: Change in salivary viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Evaluation of upper back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Evaluation of lower back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Evaluation of pelvic girdle pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: First attempt success rate of endotracheal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Receipt of Combined Tobacco Dependence Treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Intratidal gas distribution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to WHO recommendations on physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Diagnosis of early postoperative infections
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnosis of bacterial donor-derived infections
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects with non-SAEs and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Fitness test validation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axillary seroma evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Urinary excretion of aluminum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Accuracy of CART-I plus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of executive function difficulties
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: 1-year Progression-Free-Survival (PFS) rate
Endpoint domain: Mortality/survival
Primary endpoint: application time of intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbF% evaluated from central laboratory assessments at Month 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Completion rate (Objective Feasibility)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Behavior Rating Inventory of Executive Function (BRIEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Asthma control tests (CAT)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequencies of acute attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with non-accidental death or major ipsilateral stroke
Endpoint domain: Mortality/survival
Primary endpoint: Aneurysm occlusion rate on follow-up angiogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of TMAN detection after index detection of serrated lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of metachronous high-risk adenoma (HRA) after index detection of high-grade dysplasia (HGD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of headache days/month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUECPL 5-240
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Emax PL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline functional MRI BOLD signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum keratometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: front and back elevation of the apex
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distalization amount of maxillary first molars
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Agreement of blood glucose concentrations from CGM vs intermittent monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Difference in number of episodes of hypoglycemia diagnosed with CGM vs intermittent glucose monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Recovery rate of urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in Sagittal Cobb angles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total Lumbar Lordosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Prior to Intra-arterial Calcium Channel Blocker Administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain After Intra-arterial Calcium Channel Blocker Administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade 2 or greater oculocardiac reflex
Endpoint domain: Adverse events/effects
Primary endpoint: Cumulative Rates of Clinical Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MBSR course participation rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Six spot step test (SSST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WHO5 wellbeing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total body clearance (CL/F) of XNW4107, imipenem and cilastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration (Cmax) of XNW4107, imipenem and cilastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal elimination half-life (t1/2) of XNW4107, imipenem and cilastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early HCC recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Ventilation-perfusion matching (V/Q match%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Maximum endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Short-term postoperative complications rate
Endpoint domain: Adverse events/effects
Primary endpoint: Motivation to stop smoking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of RV events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximum plasma concentration (Cmax) of brexpiprazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under Curve (AUC) of brexpiprazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Disease Relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Diabetic Ketoacidosis (DKA) Events
Endpoint domain: Adverse events/effects
Primary endpoint: Measurement of skeletal muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Measurement of platelet CoQ10 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of clean implant surface area
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of overweight defined as BMI > 25
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Level of blood pressure, both systolic and diastolic levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 24h equivalent oral morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to reach full enteral feeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in patterns of 30 day substance use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sexual behavior
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Attitudes toward Transgender Men and Women
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Visceral adiposity index (VAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: chest x-ray results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Kinematic Analysis of Upper and Lower Limb Dynamics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Level of maximal oxygen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of self-collected skin samples for diagnosing scabies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of professionally-collected skin samples for diagnosing scabies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Walking Index for Spinal Cord Injury - II (WISCI-II)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Potential biomarkers in mild ARDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression of ARDS severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pervasive Developmental Disorder Behavior Inventory (PDDBI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The Symptom Checklist-90-Revised (SCL-90-R)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of Participants Completing at Least 50% of the MindTrails Sessions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Participant Perceptions of Perceived Benefits and Limitations of MindTrails
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Protocol completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Accuracy of Clearblue Pregnancy Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Cycloplegic Spherical Equivalent Refraction (cSER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hysteroscopic results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of adverse events greater than Grade 2
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of termination of taking investigational product
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in Insulin Resistance (IR) at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline in oxidative stress markers Superoxide Dismutase (SOD), Catalase (CAT) and Glutathione Peroxidase (GPX)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: superiority of adjunct intra-arterial thrombolysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrabony fill
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Quality of soft tissue regenerated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quantity of soft tissue regenerated (Width of Keratinized Tissue)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compound response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive peritoneal cytology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of HPV vaccination initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of HPV vaccination completion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommended dose for phase II trial RP2D
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: symptomatic intracranial hemorrhage (sICH)
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Time in treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pepsinogen-1 serum level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in spider fear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in avoidance behavior
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: methadone treatment retention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: In treatment overdose
Endpoint domain: Adverse events/effects
Primary endpoint: Number of adverse events grade 3 or higher
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants receiving minimum heating duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Reliability (test-retest variability within subjects)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCV Treatment Initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCV Sustained Virologic Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: spirometry tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total dose of vasopressors and inotropics used
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Diabetes Self-Care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Behavior Automaticity
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: Completion rate of prehabilitation program
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Safety Tolerance Evaluation
Endpoint domain: Adverse events/effects
Primary endpoint: spleen stiffness measurement (SSM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypoglycemia Fear Survey (HFS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diabetes Empowerment Scale (DES-Short Form)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Psychological Insulin Resistance Scale (PIRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Insulin Therapy Assessment Scale (ITAS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite neonatal outcome of large-gestational age and preterm birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LINC00657 level in salivary samples
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Hemoglobin A1c From Baseline to 6 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Hemoglobin A1c From Baseline to 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Value created in managing psoriasis patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Objective Response (OR) for Participants with B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Objective Response (OR) for Participants with Diffuse Large B-Cell Lymphoma (DLBCL)/Burkitt Lymphoma, Neuroblastoma, and Ewing Sarcoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Lower extremity pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms of infantile colic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in BOLD signal in response to alcohol/pill cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Increase in fNIRs signal response to pill/alcohol cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Higher levels of abstinence 90-days post-treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prevalence of skin sensitization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of adrenal diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with complications of adrenal diseases
Endpoint domain: Adverse events/effects
Primary endpoint: Visual Acuity Testing (Snellen units)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Slit Lamp examination (normal/abnormal)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optical Coherence Tonometry (μm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fundus Examination (normal/abnormal)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact on social behaviors using Cyberball
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Impact on social behaviors using the Trust Game
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Neurological impacts measured by fMRI imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes